Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-09-11

FDA Approved: INFED — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

FDA approved a supplemental application for INFED (iron dextran) by Allergan, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INFED (iron dextran)

Snippet

SUPPL AP for INFED (IRON DEXTRAN)